Deborah Weitzman, CEO, Pharmaceutical Segment: Cardinal Health CAH Sell · Filed 23/08/29

Trade details

Type: Insider sale
Amount: $602,804.72
Shares · price: 6,712 sh · $89.81 a share
Held after: 44,202 sh
Stock: Cardinal Health CAH
Person: Deborah WeitzmanCEO, Pharmaceutical Segment
Trade date: 23/08/28
Filed: 23/08/29
Days to filing: 1 days

Sold 13.2% of holdings

Share of holding sold: 13.2%

Cardinal Health trades, last 26 weeks

What else happened in Cardinal Health around then

Filed or reported within 30 days of the trade day · 23/07/29~23/09/27

Deborah Weitzman's recent trades

Deborah WeitzmanCEO, PSS Segment
Planned saleCardinal Health
Planned sale
Cardinal Health
CAH
$1.7M
7,354 sh
$1.7M
Filed 08/18
Traded 08/18
Deborah WeitzmanCEO, PSS Segment
Planned saleCardinal Health
Planned sale
Cardinal Health
CAH
$3.2M
21,367 sh
$3.2M
Filed 25/08/20
Traded 25/08/20
Deborah WeitzmanCEO, PSS Segment
SellCardinal Health
Sell
Cardinal Health
CAH
$3.2M
21,367 sh
$3.2M
Filed 25/08/20
Traded 25/08/20
Deborah WeitzmanCEO, Pharmaceutical Segment
Sell10b5-1 planCardinal Health
Sell10b5-1 plan
Cardinal Health
CAH
$3.9M
36,642 sh
$3.9M
Filed 23/11/29
Traded 23/11/27